Internal Medicine, Pulmonary Disease · New York, NY
NPI
1548333552
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
198 Canal Street, Suite 602
New York, NY, 10013
Phone (212) 693-1800
Groups this clinician bills Medicare through
Medicare paid, 2024
$58K
1,863 services
Medicare patients, 2024
93
Average age 81
Drug cost, 2024
$2.8M
21,287 prescriptions
Company payments, 2025
$68.05
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Thomas K Chan was code 99214 (office e&m - established), 210 times for 86 patients. In total Thomas K Chan billed 1,863 services in 23 codes, and Medicare paid $58K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-11-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 210 | 86 | $108.80 | $23K |
| 94664 E&M - Miscellaneous | Office | 192 | 76 | $16.27 | $3,125 |
| 95012 Pulmonary | Office | 98 | 44 | $17.23 | $1,688 |
| 99215 Office E&M - Established | Office | 72 | 38 | $154.58 | $11K |
| 94728 Pulmonary Function Testing | Office | 69 | 55 | $38.79 | $2,677 |
| 94729 Pulmonary Function Testing | Office | 52 | 48 | $51.44 | $2,675 |
| 94727 Pulmonary Function Testing | Office | 51 | 48 | $40.31 | $2,056 |
| 94060 Pulmonary Function Testing | Office | 50 | 47 | $35.25 | $1,762 |
| 94375 Pulmonary Function Testing | Office | 36 | 35 | $33.97 | $1,223 |
| 93000 Electrocardiogram | Office | 21 | 17 | $12.23 | $257 |
| 90661 Vaccine Product | Office | 11 | 11 | $36.11 | $397 |
By year: 2022 $117K for 3,994 services; 2023 $92K for 3,644 services; 2024 $58K for 1,863 services.
Medicare prescription drug claims, 2024
In 2024, the drug Thomas K Chan prescribed most often to Medicare patients was Montelukast Sodium, with 4,655 prescriptions and refills. In total Thomas K Chan wrote 21,287 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 4,655 | 5,215 | 629 | $22K |
| Fluticasone Propionate Generic | 3,018 | 3,083 | 514 | $35K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 2,393 | 2,448 | 442 | $58K |
| Combivent Respimat Ipratropium/Albuterol Sulfate | 1,598 | 1,654 | 260 | $793K |
| Breo Ellipta Fluticasone/Vilanterol | 1,025 | 1,050 | 153 | $412K |
| Azelastine Hcl Generic | 1,024 | 1,078 | 186 | $23K |
| Arnuity Ellipta Fluticasone Furoate | 824 | 857 | 112 | $185K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 820 | 848 | 123 | $88K |
| Atorvastatin Calcium Generic | 427 | 683 | 63 | $2,204 |
| Mometasone Furoate Generic | 413 | 500 | 74 | $44K |
| Incruse Ellipta Umeclidinium Bromide | 409 | 437 | 59 | $150K |
| Prednisone Generic | 262 | 262 | 144 | $505 |
| Amlodipine Besylate Generic | 255 | 336 | 32 | $845 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 244 | 248 | 35 | $157K |
| Advair Diskus Fluticasone Propion/Salmeterol | 228 | 266 | 46 | $53K |
Brand drugs: - claims; generic drugs: 14,343 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Thomas K Chan $68.05 ($68.05 in general payments such as food, travel and fees) from 1 company. The largest payer was GlaxoSmithKline, LLC. with $68.05.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 4 | $68.05 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.